Sex, number of prior ESS, presence of comorbid asthma, presence of N-ERD, baseline NPS, baseline SNOT-22, baseline EOS, baseline IgE, and presence of hyposmia had no significant independent impact on NPS outcome after dupilumab treatment (p > 0.05). The gene discussed is IGHE; the disease is asthma.